St. Georges University Hospital

London SW170QT

4 studies enrolling now · 11 studies all time

What they study most

Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Cardiac Electrophysiology, Catecholamine-resistant Hypotension (CRH), Distributive Shock, High Output Shock, Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer, Myasthenia Gravis, Generalized, Myelodysplastic Syndrome, Myotonic Dystrophy 1, Myotonic Dystrophy Type 1 (DM1), Parkinson's Disease

Studies at this site

• A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis — Recruiting now
• A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Study of ATX-01 in Participants With DM1 — Recruiting now
• Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation — Completed
• Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children — Completed
• Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy — Stopped early
• Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations — Running, not enrolling
• Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) — Running, not enrolling
• Transvenous Lead Removal Post-Market Clinical Study — Completed
• A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension — Completed